Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

NCT00609856 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Secondary Drug Failure

Interventions

DRUG: pioglitazone
DRUG: insulin glargine

Sponsor

Skane University Hospital

Collaborators

[object Object]
[object Object]